Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.4550
-0.0200 (-4.21%)
May 8, 2026, 4:28 PM GMT
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 7.19 million as of May 8, 2026. Its market cap has increased by 58.07% in one year.
Market Cap
7.19M
Enterprise Value
7.05M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 7.19M, a decrease of -86.11%. That is a compound annual growth rate of -30.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 7.19M | -34.48% |
| Dec 31, 2025 | 10.97M | 16.74% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.50B |
| GSK plc | 74.19B |
| Haleon | 29.76B |
| Smith & Nephew | 9.51B |
| CelLBxHealth | 9.94M |
| Oxford BioDynamics | 7.94M |
| GENinCode | 7.91M |
| Renalytix | 7.87M |